HOME Life Sciences Technology

Sofinnova Partners is an independent venture capital firm based in Paris. We invest in early stage companies, corporate spin-offs and turnaround situations in the technology and life sciences spaces, including cleantech:

  • 460 companies financed in Europe since 1972
  • Over 1 in 5 companies financed have gone public
  • Over 1 in 5 companies financed have been acquired
  • 40 jobs created per company on average between financing and exit
  • Revenues multiplied by 8 on average between financing and exit.

«Our job is an interesting blend—
we are both investors and entrepreneurs.»
Jean-Bernard Schmidt

Managing Partner

In Life Sciences, Sofinnova Partners focuses on ambitious projects developing new therapeutics in both biopharmaceuticals and medical devices.
Priority is given to companies that :

  • develop new products for unmet clinical needs and with early clinical proof of concept
  • address big markets: from oncology to diseases of the central nervous system, from metabolic to infectious diseases
  • combine entrepreneurial with pharmaceutical experience.

The disruptive technologies that Sofinnova concentrate on may lead us to deals in the cleantech field such as biofuel, green chemicals, waste management, water treatment....

Endotis Pharmaceuticals Cellzome Creabilis Therapeutics Diatos

In the Technology sector, Sofinnova Partners focuses on disruptive technologies and business models in areas that include:

  • telecommunication/consumer electronics and wireless devices
  • wireless internet, internet
  • other technologies and markets including energy or photonics.

The disruptive technologies that we concentrate on may lead us to deals in the cleantech sector including alternative energy, storage, efficiency...

WyPlay SAS Musinaut / MXP4 Varioptic Accent spa

The News

Entrepreneur Section


Sofinnova Rss feed

Click here for the site of Sofinnova Ventures, our sister firm in San Francisco http://www.sofinnova.com